Filing Details
- Accession Number:
- 0000711377-10-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-12 16:50:24
- Reporting Period:
- 2010-10-07
- Filing Date:
- 2010-10-12
- Accepted Time:
- 2010-10-12 16:50:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189001 | H Thomas Reed | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-10-07 | 215 | $8.18 | 1,903 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-10-07 | 215 | $34.04 | 1,688 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-10-08 | 599 | $8.18 | 2,287 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-10-08 | 599 | $34.07 | 1,688 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-10-11 | 1,967 | $8.18 | 3,655 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-10-11 | 1,967 | $34.00 | 1,688 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-10-11 | 4,500 | $9.02 | 6,188 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-10-11 | 4,500 | $34.00 | 1,088 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-10-11 | 2,000 | $16.71 | 3,688 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-10-11 | 2,000 | $34.00 | 1,688 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-10-11 | 1,000 | $16.53 | 2,688 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-10-11 | 1,000 | $34.00 | 1,688 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Option (Right to buy) | Disposition | 2010-10-07 | 215 | $0.00 | 215 | $8.18 |
| Common Stock | Common Stock Options (Right to buy) | Disposition | 2010-10-08 | 599 | $0.00 | 599 | $8.18 |
| Common Stock | Common Stock Option (Right to buy) | Disposition | 2010-10-11 | 1,967 | $0.00 | 1,967 | $8.18 |
| Common Stock | Common Stock Option (Right-to-buy) | Disposition | 2010-10-11 | 4,500 | $0.00 | 4,500 | $9.02 |
| Common Stock | Common Stock Option (Right to buy) | Disposition | 2010-10-11 | 2,000 | $0.00 | 2,000 | $16.71 |
| Common Stock | Common Stock Option (Right to buy) | Disposition | 2010-10-11 | 1,000 | $0.00 | 1,000 | $16.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,066 | 2015-10-31 | No | 4 | M | Direct | |
| 12,467 | 2015-10-31 | No | 4 | M | Direct | |
| 10,500 | 2015-10-31 | No | 4 | M | Direct | |
| 6,000 | 2006-11-03 | No | 4 | M | Direct | |
| 4,000 | 2017-10-11 | No | 4 | M | Direct | |
| 3,000 | 2018-10-10 | No | 4 | M | Direct |
Footnotes
- The options were granted 10/31/05 as Non-Qualified stock options and became exercisable 33% yearly thereafter.
- The options were granted 11/3/06 as Non-Qualified stock options and became exercisable 33% yearly thereafter
- The options were granted 10/11/07 as Non-Qualified stock options and became exercisable 33% yearly thereafter
- The options were granted 10/10/08 as Non-Qualified stock options and became exercisable 33% yearly thereafter.
Billionaire Hedge Funds
